Difference between revisions of "SPECT Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
Line 23: Line 23:
 
==Working Documents==
 
==Working Documents==
  
==Literature Review(Profile 1.0)==
+
==Literature Review (Profile 1.0)==
 
*[[Media:QIBA SPECT Literature Review-22 March 2016.pdf |  QIBA Literature Review Slides for Profile 1.0 - Dr. Seibyl]] ''March 22, 2016''
 
*[[Media:QIBA SPECT Literature Review-22 March 2016.pdf |  QIBA Literature Review Slides for Profile 1.0 - Dr. Seibyl]] ''March 22, 2016''
  

Revision as of 20:46, 22 March 2016

Project Snapshot

The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.


Under consideration:

  • quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
  • quantifying organs, like the liver, for dosimetry as potential use cases


Established Task Forces Currently Working Toward a first Profile with title as follows below:

Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease

  • Image Acquisition and Image Processing for DaTscan – Dr. Dewaraja
  • Quantitative / Image Analysis – Drs. Miyaoka and Seibyl
  • Phantoms / DRO Group – Drs. Dickson and Zimmerman
  • Clinical / Literature Review – Dr. Seibyl

Meetings/Call Summaries


Working Documents

Literature Review (Profile 1.0)

Profile Development

Archived versions of the Profile

Statistical Reference Documents

Workflow Documents

Reference Materials